Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matthew Caufield is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/14/2025 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 1112.86% | Matthew Caufield37% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 03/12/2025 | ZBIO | Buy Now | Zenas BioPharma | $7.90 | 279.75% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 03/10/2025 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 03/10/2025 | UBX | Buy Now | Unity Biotechnology | $1.81 | 341.87% | Matthew Caufield37% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2025 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 51.95% | Matthew Caufield37% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2025 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2025 | IMUX | Buy Now | Immunic | $1.14 | 777.19% | Matthew Caufield37% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 02/19/2025 | IRD | Buy Now | Opus Genetics | $1.15 | 596.62% | Matthew Caufield37% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2025 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2025 | FBLG | Buy Now | FibroBiologics | $1.02 | 1076.47% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 02/06/2025 | EYEN | Buy Now | Eyenovia | $1.55 | 29.03% | Matthew Caufield37% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 01/30/2025 | SRZN | Buy Now | Surrozen | $11.00 | 190.91% | Matthew Caufield37% | → $32 | Initiates | → Buy | Get Alert |
| 01/29/2025 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 01/03/2025 | OPTN | Buy Now | OptiNose | $5.85 | 207.69% | Matthew Caufield37% | $5 → $18 | Maintains | Buy | Get Alert |
| 12/16/2024 | ZBIO | Buy Now | Zenas BioPharma | $7.90 | 279.75% | Matthew Caufield37% | → $30 | Initiates | → Buy | Get Alert |
| 12/12/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | IRD | Buy Now | Opus Genetics | $1.15 | 596.62% | Matthew Caufield37% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 11/25/2024 | IMUX | Buy Now | Immunic | $1.14 | 777.19% | Matthew Caufield37% | → $10 | Initiates | → Buy | Get Alert |
| 11/19/2024 | ADVM | Buy Now | Adverum Biotechnologies | $5.07 | 491.72% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 11/18/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 29.03% | Matthew Caufield37% | $960 → $160 | Downgrade | Buy → Neutral | Get Alert |
| 11/15/2024 | KOD | Buy Now | Kodiak Sciences | $3.24 | -7.41% | Matthew Caufield37% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 11/15/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $5.70 | 22.81% | Matthew Caufield37% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | FBLG | Buy Now | FibroBiologics | $1.02 | 1076.47% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | OPTN | Buy Now | OptiNose | $5.85 | -14.53% | Matthew Caufield37% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2024 | LENZ | Buy Now | LENZ Therapeutics | $24.00 | 58.33% | Matthew Caufield37% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 10/31/2024 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 10/30/2024 | FBLG | Buy Now | FibroBiologics | $1.02 | 1076.47% | Matthew Caufield37% | → $12 | Initiates | → Buy | Get Alert |
| 10/10/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $5.70 | 22.81% | Matthew Caufield37% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 10/07/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $5.70 | 22.81% | Matthew Caufield37% | → $7 | Initiates | → Buy | Get Alert |
| 09/24/2024 | KOD | Buy Now | Kodiak Sciences | $3.24 | -7.41% | Matthew Caufield37% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 09/19/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | KOD | Buy Now | Kodiak Sciences | $3.24 | -7.41% | Matthew Caufield37% | → $3 | Initiates | → Neutral | Get Alert |
| 09/03/2024 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield37% | $14 → $12 | Maintains | Buy | Get Alert |
| 08/15/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 1112.86% | Matthew Caufield37% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 08/15/2024 | LENZ | Buy Now | LENZ Therapeutics | $24.00 | 58.33% | Matthew Caufield37% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | $20 → $18 | Maintains | Buy | Get Alert |
| 08/15/2024 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 08/13/2024 | ADVM | Buy Now | Adverum Biotechnologies | $5.07 | 491.72% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 08/13/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | HLVX | Buy Now | HilleVax | $1.72 | 16.28% | Matthew Caufield37% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 08/12/2024 | LENZ | Buy Now | LENZ Therapeutics | $24.00 | 58.33% | Matthew Caufield37% | → $38 | Initiates | → Buy | Get Alert |
| 08/12/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 51.95% | Matthew Caufield37% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/02/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 51.95% | Matthew Caufield37% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 07/24/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 07/19/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 07/10/2024 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | → $30 | Initiates | → Buy | Get Alert |
| 07/09/2024 | HLVX | Buy Now | HilleVax | $1.72 | — | Matthew Caufield37% | — | Downgrade | Buy → Neutral | Get Alert |
| 06/07/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | OPTN | Buy Now | OptiNose | $5.85 | -14.53% | Matthew Caufield37% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | HLVX | Buy Now | HilleVax | $1.72 | 1527.91% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | ADVM | Buy Now | Adverum Biotechnologies | $5.07 | 491.72% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 1112.86% | Matthew Caufield37% | → $2 | Downgrade | Buy → Neutral | Get Alert |
| 05/06/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 51.95% | Matthew Caufield37% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 7177.14% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 04/30/2024 | ADVM | Buy Now | Adverum Biotechnologies | $5.07 | 491.72% | Matthew Caufield37% | → $30 | Initiates | → Buy | Get Alert |
| 04/29/2024 | OPTN | Buy Now | OptiNose | $5.85 | -14.53% | Matthew Caufield37% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 04/02/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 51.95% | Matthew Caufield37% | → $10 | Reinstates | Buy → Buy | Get Alert |
| 03/22/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 7177.14% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2024 | HLVX | Buy Now | HilleVax | $1.72 | 1527.91% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2024 | OPTN | Buy Now | OptiNose | $5.85 | -14.53% | Matthew Caufield37% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 03/11/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 03/11/2024 | OPTN | Buy Now | OptiNose | $5.85 | -14.53% | Matthew Caufield37% | → $75 | Initiates | → Buy | Get Alert |
| 03/08/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
| 03/01/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 12/13/2023 | HLVX | Buy Now | HilleVax | $1.72 | 1527.91% | Matthew Caufield37% | → $28 | Initiates | → Buy | Get Alert |
| 11/14/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2023 | UBX | Buy Now | Unity Biotechnology | $1.81 | 452.33% | Matthew Caufield37% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | Buy → Buy | Get Alert |
| 10/02/2023 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 7177.14% | Matthew Caufield37% | → $12 | Reiterates | Buy → Buy | Get Alert |
| 08/31/2023 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 7177.14% | Matthew Caufield37% | → $12 | Initiates | → Buy | Get Alert |
| 08/22/2023 | FN | Buy Now | Fabrinet | $222.86 | -87.44% | Matthew Caufield37% | → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/18/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | Buy → Buy | Get Alert |
| 08/10/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | → $28 | Initiates | → Buy | Get Alert |
| 08/09/2023 | UBX | Buy Now | Unity Biotechnology | $1.81 | 452.33% | Matthew Caufield37% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/01/2023 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield37% | → $14 | Reiterates | Buy → Buy | Get Alert |
| 07/31/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | Buy → Buy | Get Alert |
| 06/30/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/22/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/16/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/08/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2023 | UBX | Buy Now | Unity Biotechnology | $1.81 | 452.33% | Matthew Caufield37% | → $10 | Reiterates | → Buy | Get Alert |
| 05/05/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | → Buy | Get Alert |
| 05/02/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | $35 → $40 | Downgrade | Buy → Neutral | Get Alert |
| 04/28/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | → Buy | Get Alert |
| 04/19/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | → Buy | Get Alert |
| 04/03/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | → $20 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | UBX | Buy Now | Unity Biotechnology | $1.81 | 452.33% | Matthew Caufield37% | → $10 | Reiterates | → Buy | Get Alert |
| 03/16/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | → Buy | Get Alert |
| 03/10/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | → Buy | Get Alert |
| 03/02/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | → $35 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield37% | → $14 | Reiterates | → Buy | Get Alert |
| 02/23/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | → $20 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | → $35 | Reiterates | → Buy | Get Alert |
| 02/06/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | → Buy | Get Alert |
| 01/26/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | $26 → $20 | Maintains | Buy | Get Alert |
| 12/08/2022 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield37% | → $14 | Initiates | → Buy | Get Alert |
| 11/18/2022 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Initiates | → Buy | Get Alert |
| 11/04/2022 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | $26 → $35 | Maintains | Buy | Get Alert |
| 10/05/2022 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Initiates | → Buy | Get Alert |
| 07/18/2022 | OYST | Buy Now | Oyster Point Pharma | — | — | Matthew Caufield37% | → $20 | Initiates | → Buy | Get Alert |
| 11/10/2021 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | $20 → $26 | Maintains | Buy | Get Alert |
| 08/19/2021 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | → $20 | Initiates | → Buy | Get Alert |
